Last Updated: August 7, 2026
The Milwaukee Guide to Ketamine and Psychedelic Therapy
If you are searching for ketamine therapy near me in Milwaukee, or for psychedelic therapy near me in Milwaukee, this guide lays out what is actually available across the metro, what each option costs, and what is legal in Wisconsin. As of 2026, Wisconsin ranks 21st of 51 states and DC on Mental Health America's Access to Care measure¹, a middle-of-the-pack position, and the Milwaukee area pairs an established set of in-clinic ketamine providers with at-home telehealth care. Below you will find every path, at-home therapy, in-clinic IV or IM ketamine, Spravato, and where psychedelics like psilocybin actually stand, plus who each option fits and how to begin.

Key takeaways
- Ketamine is legal and available now in Wisconsin: an FDA Schedule III medication that eligible adults can access at a Milwaukee clinic or at home via telehealth, after an online clinical evaluation.
- In-clinic ketamine in the Milwaukee area runs about $300 to $600 or more per session, with a six-infusion series roughly $2,400 to $3,600² ³, while at-home therapy with Mindbloom is $165 to $215 per session.
- Psilocybin and MDMA are not legal for therapy in Wisconsin: psilocybin is Schedule I with no state program and no Milwaukee decriminalization⁴, so ketamine is the psychedelic-class therapy you can legally start now.
- Wisconsin sits 21st of 51 on Mental Health America's Access to Care measure¹, a middle position that makes convenient, at-home options especially useful for people who would otherwise travel to a clinic.
- Mindbloom has delivered more than 800,000 guided at-home sessions and is the only at-home ketamine provider with peer-reviewed PTSD outcomes⁶.
The Options in Milwaukee, Briefly
Milwaukee offers several distinct routes to ketamine care, plus a few things people search for as psychedelic therapy that are worth being precise about. Here is each option in plain terms, with no ranking implied.
At-home ketamine and psychedelic therapy (Mindbloom). A licensed clinician evaluates you online, and if ketamine is a good fit, you complete clinician-guided sessions at home using sublingual tablets or subcutaneous injections, with remote monitoring and support. Cost is $165 to $215 per session within the program, available across Wisconsin via telehealth.
In-clinic ketamine (IV or IM). Milwaukee-area clinics provide intravenous or intramuscular ketamine in a medical setting with staff present. Edelica Health, which describes itself as the first dedicated ketamine clinic in Wisconsin with more than 7,000 infusions delivered, posts $300 for a nasal mood treatment and $475 for an IV mood infusion², and Reset Restore MD in Brookfield and Mequon lists IV infusions at $400 to $600 or more per session, or roughly $2,400 to $3,600 for a six-session series³.
Spravato (esketamine). This FDA-approved nasal spray is offered at certified Milwaukee-area clinics such as American Behavioral Clinics and Relief Mental Health in West Allis. It is administered in-clinic with monitoring, and may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is paid out of pocket.
Clinical trials. Research studies are the main lawful route to psychedelics such as psilocybin or MDMA in Wisconsin, since neither is available for therapy outside a trial. Availability is limited and eligibility is study-specific.
Which One Fits You
A quick way to narrow the field, matched to what matters most to you:
- If 100% bioavailibility is important and you prefer on-site monitoring, an in-clinic ketamine provider in the Milwaukee area is a natural fit.
- If you have treatment-resistant depression and want a route that insurance may help cover, Spravato at a certified clinic is worth asking your prescriber about.
- If you prefer treatment at home on your own schedule with a licensed clinician guiding the program, at-home ketamine therapy through Mindbloom fits that preference.
- If you are specifically drawn to psilocybin or MDMA, note that neither is legally available for therapy in Wisconsin today, so a clinical trial is the primary route to consider.
Ketamine and Psychedelic Therapy Near You Across the Milwaukee Area
At-home ketamine therapy is available anywhere in the Milwaukee metro with a private space and an internet connection, so the same care reaches you in the city and across the surrounding suburbs. That includes Wauwatosa, West Allis, Waukesha, Brookfield, Mequon, Oak Creek, Franklin, Greenfield, New Berlin, and Menomonee Falls.
In-clinic ketamine and Spravato providers are more concentrated. The metro's named clinics cluster along Milwaukee's west side and in the western and northern suburbs such as Brookfield, Mequon, and West Allis. If you are searching for ketamine therapy providers or a psychedelic therapist near me and live outside those pockets, at-home care removes the drive entirely while keeping a licensed clinician involved.
Is Ketamine, Psilocybin, or Psychedelic Therapy Legal in Wisconsin?
Is ketamine legal in Wisconsin? Yes. Ketamine is an FDA-approved Schedule III medication, which means licensed clinicians can legally prescribe it, including for off-label mental health use and through telehealth. Eligible adults in Milwaukee can begin ketamine therapy now, whether in a clinic or at home, once a clinician confirms it is a good fit.
Is psilocybin legal in Wisconsin? No. Psilocybin is a Schedule I substance under state law, with no licensed-therapy program and no decriminalization ordinance in Milwaukee, Madison, or elsewhere in the state⁴. The most recent legislative effort, Senate Bill 727, proposed only a narrow University of Wisconsin research pilot studying psilocybin for veterans with treatment-resistant PTSD, and it did not pass⁵. MDMA-assisted therapy is not FDA-approved in the United States, and other psychedelics such as LSD and ayahuasca are likewise not legally available for therapy or offered as a Mindbloom service.
So if you are exploring psilocybin therapy in Wisconsin, MDMA therapy for PTSD, or simply searching for mushrooms for depression near me, the accurate picture is that these are not lawful therapeutic options in the state today. Ketamine is the one psychedelic-class therapy that eligible adults can legally start now in Milwaukee, including from home with Mindbloom.
Why People Choose At-Home Care with Mindbloom
Mindbloom is one of the largest at-home psychedelic-therapy providers, with more than 800,000 guided sessions delivered. Its approach is built around real clinical evidence: a peer-reviewed study of its at-home subcutaneous protocol (Parks 2026) reporting outcomes for depression, anxiety, and PTSD in a single study⁶, two earlier peer-reviewed studies of its sublingual protocol (Hull 2022 and Mathai 2024), and research preprints extending the evidence to grief, burnout, and sleep. Mindbloom is the only at-home ketamine provider with peer-reviewed PTSD outcomes.
Subcutaneous dosing is a genuine differentiator, and Mindbloom's published subcutaneous outcomes are summarized below. How at-home sublingual compares with in-clinic IV is covered in Mindbloom's comparison of sublingual and IV ketamine. Individual results vary.
⁶ Subcutaneous, six-session course (Parks 2026). Response = at least a 50% reduction (PHQ-9 or GAD-7) or at least 10 points (PCL-5); remission = final PHQ-9 or GAD-7 below 5, or at least a 10-point reduction with PCL-5 below 33. ⁷ ⁸ ⁹ Grief, burnout, and sleep figures come from Mindbloom research preprints (Swain et al. 2026). ᵃ Grief remission = no longer met diagnostic criteria (71.1%). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0); sleep is a single-item measure and ketamine is off-label for sleep. Individual results vary.
Beyond a prescription, Mindbloom offers tailored programs that use the psychedelic modality to address specific outcomes rather than only medicating them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.
How Mindbloom's reported outcomes compare with named studies of other treatments:
- Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs about 41%), and reached faster.⁶ ¹⁰
- Mindbloom's reported anxiety response rate is about 29% higher than the rate reported in a study of CBT for generalized anxiety (60.6% vs 47%), in about half the time.⁶ ¹¹
- Mindbloom's reported PTSD response rate is about 32% higher than the rate reported in a study of first-line SSRIs (76.7% vs 58%).⁶ ¹²
- Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37% to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.⁶ ¹³
How At-Home Ketamine Therapy Works
At-home care with Mindbloom starts with an online evaluation by a licensed clinician who reviews your history and decides whether ketamine is appropriate. If approved, you receive a personalized, clinician-guided program rather than a single prescription, with treatment frequency set by your clinician.
Each session happens in your own space. You prepare with a guide, complete the dosing session with support available, and follow with integration to make sense of the experience. For many clients this combines rapid initial relief with cumulative benefit built over the course of the program.
Safety, Candidacy, and Cost
Ketamine therapy is a prescription medical treatment, and its safety comes from the clinical structure around it. A licensed clinician confirms eligibility before treatment begins, and Mindbloom builds in preparation, monitoring, and follow-up. It is available to eligible adults, not on demand, and a clinician may determine it is not the right fit.
At-home ketamine therapy with Mindbloom is $165 to $215 per session within its program (see current program pricing), generally less than in-clinic ketamine in the Milwaukee area. Most ketamine therapy for mood conditions is off-label and paid out of pocket, whether in-clinic or at home, though Mindbloom accepts HSA and FSA funds and can provide paperwork for possible out-of-network reimbursement. Eligibility begins with an online clinical evaluation. You can start there or learn more on Mindbloom's main site.
Frequently asked questions
Is ketamine therapy legal in Wisconsin?
Yes. Ketamine is an FDA-approved Schedule III medication, and licensed clinicians can prescribe it for mental health conditions, including through telehealth. In Wisconsin, eligible adults can access ketamine therapy in person at a Milwaukee-area clinic or at home through a telehealth provider such as Mindbloom, after an online clinical evaluation confirms it is a good fit.
How do I get ketamine treatment near me in Milwaukee?
There are two main routes. You can visit an in-clinic ketamine provider in the Milwaukee area for IV or IM sessions, or you can start at-home ketamine therapy through a telehealth provider like Mindbloom, which begins with an online evaluation by a licensed clinician who decides whether to prescribe. In-clinic care means traveling to a clinic for each session; at-home care is done from your own home with clinician guidance and remote support.
Is psilocybin or psychedelic therapy legal in Wisconsin?
No. Psilocybin remains a Schedule I substance in Wisconsin, with no statewide licensed-therapy program and no local decriminalization in Milwaukee. MDMA-assisted therapy is not FDA-approved anywhere in the United States. Because these psychedelics are not legally available for therapy in Wisconsin today, ketamine is the psychedelic-class therapy that eligible adults can legally begin now, including from home with Mindbloom.
How much does ketamine therapy cost in Milwaukee?
In-clinic ketamine in the Milwaukee area generally runs from about $300 to $600 or more per session depending on the clinic, the route, and the condition treated, with a typical in-clinic series of six infusions totaling roughly $2,400 to $3,600. At-home ketamine therapy with Mindbloom is $165 to $215 per session within its program, and Mindbloom accepts HSA and FSA funds and can provide paperwork for possible out-of-network reimbursement.
Can ketamine therapy help with depression?
Depression is the most common reason people seek ketamine therapy, and it is Mindbloom's primary indication. In Mindbloom's peer-reviewed study of its at-home subcutaneous protocol, 56.6% of clients responded and 27.7% reached remission for depression. Individual results vary, and eligibility is confirmed by a licensed clinician before treatment begins.
Is at-home ketamine therapy as effective as going to a clinic for IV?
At-home and in-clinic ketamine use different routes, and both are used for treatment-resistant mood conditions. Mindbloom's at-home care uses subcutaneous and sublingual ketamine with clinician guidance and remote monitoring, and its peer-reviewed subcutaneous outcomes report a 76.7% PTSD response rate, which exceeds the rate reported in the leading repeated-infusion IV ketamine trial. The main practical difference is convenience: at-home therapy removes the travel and per-visit clinic time while keeping a licensed clinician involved throughout.
Does ketamine therapy near me take insurance?
Most ketamine therapy for mood conditions is off-label and paid out of pocket, whether in-clinic or at home. Spravato, a related FDA-approved esketamine nasal spray offered at some Milwaukee clinics, may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is out of pocket. Mindbloom's at-home program is $165 to $215 per session, is HSA and FSA eligible, and can supply documentation for possible out-of-network reimbursement.

Mindbloom Treatment
See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.






